Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?

The type 5 metabotropic glutamate receptor, mGlu(5), has been proposed as a potential therapeutic target for the treatment of several neurodegenerative diseases. In preclinical neurodegenerative disease models, novel allosteric modulators have been shown to improve cognitive performance and reduce d...

Descripción completa

Detalles Bibliográficos
Autores principales: Budgett, Rebecca F., Bakker, Geor, Sergeev, Eugenia, Bennett, Kirstie A., Bradley, Sophie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130574/
https://www.ncbi.nlm.nih.gov/pubmed/35645791
http://dx.doi.org/10.3389/fphar.2022.893422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130574/
https://www.ncbi.nlm.nih.gov/pubmed/35645791
http://dx.doi.org/10.3389/fphar.2022.893422

Ejemplares similares